Günaydın, Ş. Et Al. 2022. Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line. 4th Eurasia Biochemical Approaches & Technologies (EBAT) 2022 , (Antalya, Turkey), 124.

Günaydın, Ş., Kalın, Ş., Karaca Sülükoğlu, E., Altay, A., & Budak, H., (2022). Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line . 4th Eurasia Biochemical Approaches & Technologies (EBAT) 2022 (pp.124). Antalya, Turkey

Günaydın, Şükran Et Al. "Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line," 4th Eurasia Biochemical Approaches & Technologies (EBAT) 2022, Antalya, Turkey, 2022

Günaydın, Şükran Et Al. "Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line." 4th Eurasia Biochemical Approaches & Technologies (EBAT) 2022 , Antalya, Turkey, pp.124, 2022

Günaydın, Ş. Et Al. (2022) . "Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line." 4th Eurasia Biochemical Approaches & Technologies (EBAT) 2022 , Antalya, Turkey, p.124.

@conferencepaper{conferencepaper, author={Şükran Günaydın Et Al. }, title={Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line}, congress name={4th Eurasia Biochemical Approaches & Technologies (EBAT) 2022}, city={Antalya}, country={Turkey}, year={2022}, pages={124} }